icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
No Resistance to Tenofovir Alafenamide Detected Through 144 Weeks of Treatment in Patients With Chronic Hepatitis B
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
 
Henry Lik-Yuen Chan,1 Patrick Marcellin,2 Calvin Q. Pan,3 Andrea L. Cathcart,4 Neeru Bhardwaj,4 Yang Liu,4 Bandita Parhy,4 Eric Zhou,4 David Hsieh,4 Silvia Chang,4 Ross Martin,4 Becket Feierbach,4 Hongmei Mo,4 Anuj Gaggar,4 John F. Flaherty,4 Shalimar,5 Namiki Izumi,6 Young-Suk Lim7
1Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; 2Hôpital Beaujon, Clichy, and Institut National de la Santé et de la Recherche Médicale-Université Paris Diderot, France; 3NYU Langone Health, New York, NY; 4Gilead Sciences, Inc., Foster City, CA; 5All India Institute of Medical Sciences, New Delhi, India; 6Japanese Musashino Red Cross Hospital, Tokyo, Japan; 7Asan Medical Center, Seoul, South Korea

1230181

1230182

1230183

1230184

1230185